As a true pioneer in neuro-musculoskeletal medical device clinical trial execution and management, the Clinical Research Organization (CRO) of Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) has built an established reputation by working to streamline the effectiveness and success of clinical trials for nearly a decade. Our exclusive focus on neuro-musculoskeletal device studies sets us apart from other CROs. Executing a successful market entry strategy involves navigating the regulatory approval process, choosing high caliber research sites, designing and conducting efficient clinical trials, and adeptly evaluating the existing marketplace. Whether it is augmenting internal staff with a functional outsourcing approach, or managing your entire medical device development program from beginning to end, we can do it, and do it more efficiently.
We offer comprehensive clinical trial services, including:
Our CRO enables orthopedic companies of all sizes to successfully execute clinical studies by streamlining the clinical trial process through an integrated approach that guides clients through the medical device lifecycle: from pre-clinical testing, to FDA submission, market approval, and post commercialization.
To contact a clinical trial expert at MCRA, call 202.552.5800 or email
Mr. Stiegman manages and directs the clinical and regulatory affairs departments for MCRA and its clients. Mr. Stiegman is responsible for management of approximately 15 clinical and regulatory professionals at MCRA. Mr. Stiegman leads the firm's submission process, regulatory strategy, analysis and development: from pre-clinical testing, to FDA submissions Read More